enVVeno Medical Corporation — Income Charts
24 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+2947.3% +$142K
$147K
Cost of Revenue
$98K
Gross Profit
$31K
R&D↑+57.0% +$1M
$3M
SG&A↓-49.2% -$4M
$4M
D&A↑+17.7% +$8K
$54K
Operating Income↓-127.2% -$3M
$-6M
EBITDA↑+17.7% +$8K
$54K
Interest Expense↓-100.0% -$103K
$0
Net Income↓-155.2% -$4M
$-6M
Gross Margin
100.0%
Operating Margin↑+280968.1pts
-59862.9%
Net Margin↑+297305.7pts
-52830.6%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-12.1pts
-5.1%
ETR Foreign Differential (pp)↑+1.5pts
2.0%
Operating Lease Cost↑+48.3% +$43K
$133K
Revenue YoY Variation↑+1512.9pts
2947.3%
Income YoY Variation↓-86.4pts
-127.2%
Revenue QoQ Variation↑+50.9pts
6.5%
Income QoQ Variation↑+25.4pts
12.0%